Effects of theophylline on lymphocyte phosphodiesterase activity

General Pharmacology

Volumn 31, Issue 3, 1998, Pages 409-413

  Tohda, Yuji ^a   Nakahara, Hiroshi ^a   Kubo, Hirokazu ^a   Ohkawa, Kentaro ^a   Fukuoka, Masahiro ^a   Nakajima, Shigenori ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Cyclic AMP; Lymphocyte phosphodisterase; Theophylline

Indexed keywords

AMINOPHYLLINE; CYCLIC AMP; PHOSPHODIESTERASE; TERBUTALINE SULFATE; THEOPHYLLINE;

ADULT; AGE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SUBCUTANEOUS DRUG ADMINISTRATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADULT; AGE FACTORS; AMINOPHYLLINE; ASTHMA; BRONCHODILATOR AGENTS; CYCLIC AMP; CYCLIC GMP; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LYMPHOCYTES; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; SEX FACTORS; TERBUTALINE; THEOPHYLLINE; TIME FACTORS;

EID: 0032167747     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00027-5     Document Type: Article

References (13)

1. Adeistein R.S., Hathway D.R. Role of calcium and cyclic adenosine 3′5′ monophosphate in regulating smooth muscle. Am. J. Card. 44:1979;783-787.
2. Boyum A. Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigens. 4:1974;269-274.
3. Butcher R.W., Sutherland E.W. Adenosine 3′5′-phosphate in biological materials I. purification and properties of cyclic 3′5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine-3′5′-phosphate in human urine J. Biol. Chem. 237:1962;1224-1250.
4. D'Armiento M., Johnson G.S., Pastan I. Regulation of adenosine 3′5′-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentration of cyclic adenosine monophosphate. Proc. Natl. Acad. Sci. USA. 69:1972;459-462.
5. Erjefält I., Persson C.G. Pharmacologic control of plasma exudation into tracheobronchial airway. Am. Rev. Respir. Dis. 143:1991;1008-1014.
6. Kakiuchi F. Regulation of phosphodiesterase activity. Taisha (Metab.). 13:1976;813-820.
7. Lohmann S.M., Miech R.P., Butcher F.R. Effects of cyclic nucleotide levels and relaxation of bovine tracheal muscle. Biochim. Biophys. Acta. 499:1977;238-250.
8. 1 effects on adenosine 3′5′-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts. Proc. Natl. Acad. Sci. USA. 69:1972;269-273.
9. Mue T., Ise T., Ono Y., Takishima T. Phosphodiesterase in leukocytes of patients with bronchial asthma. Allergy. 24:1975;490-496.
10. Okabe T., Yamamoto S., Suzuki M.et al. Method of measurement of phosphodiesterase (PDE) activity and PDE level in infants with bronchial asthma. Allergy. 35:1986;867-871.
11. Okawa K., Yamazaki K., Hiraike Y., Ohara I., Sugihara R., Tanaka A., Ohishi M., Tsuya Y., Nakajima S. Influence of theophylline administration on endogenous cyclic nucleotides in patients with bronchial asthma. Kinki Univ. Med. J. 10:1985;43-49.
12. Polson J.B., Krzanowski J.J., Goldmann A.L., Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin. Exp. Pharmac. Physiol. 5:1978;536-539.
13. Uzunov P., Shein H.M., Weiss B. Cyclic AMP phosphodiesterase in clonede astrocytoma cells. Science. 180:1973;304-306.